Cetuximab

Listen to The Lancet

17 years ago

The Lancet: May 01, 2009

monoclonal

antibody

cetuximab

lung cancer

+4

+3

+3

+2

+2

+2

+1

11:07

monoclonal

antibody

cetuximab

lung cancer

+4

+3

+3

+2

+2

+2

+1

Journal of Clinical Oncology P

14 years ago

No Advantage to Combining Cetuximab with 5FU, Leucovorin, and Oxaliplatin in Metastatic Colorectal C

chemotherapy

cetuximab

targetedtherapy

metastaticcolorectalcancer

+4

+4

+3

+3

+2

+2

+2

+1

chemotherapy

cetuximab

targetedtherapy

metastaticcolorectalcancer

+4

+4

+3

+3

+2

+2

+2

+1